Literature DB >> 25076542

Reinforcement of the pulmonary artery autograft with a polyglactin and polydioxanone mesh in the Ross operation: experimental study in growing lamb.

Francesco Nappi, Cristiano Spadaccio, Clotilde Castaldo, Franca Di Meglio, Daria Nurzynska, Stefania Montagnani, Massimo Chello, Christophe Acar.   

Abstract

BACKGROUND AND AIM OF THE STUDY: Synthetic materials used for pulmonary autograft (PA) reinforcement in the Ross procedure fail to match the demand for structural growth, have only a limited longevity, and do not guarantee adequate vascular compliance in high-pressure load systems. The study aim was to develop a resorbable reinforcement of a PA, tailored to provide structural support and to guide the process of wall structure modification for the preservation of graft viability.
METHODS: An experimental model of translocation of the pulmonary trunk as an autograft in the aortic position was developed and performed under cardiopulmonary bypass in young lambs. The PA was left without reinforcement, reinforced with standard commercially available mesh, or reinforced with resorbable mesh of polyglactin and polydioxanone.
RESULTS: Based on vessel diameter measurements by transesophageal echography at day 0 and at six months postoperatively, only the PA with resorbable reinforcement showed a behavior similar to that of the normal aorta in a growing lamb. With the non-resorbable reinforcement, transmural migration of the mesh was observed, accompanied by a conspicuous inflammatory infiltrate and fibrosis.
CONCLUSION: The resorbable mesh allowed for histological wall modification, characterized by the presence of highly organized smooth muscle cells and elastic lamellae in the media. The mechanical and histological features of this resorbable mesh-reinforced PA may be crucial to the clinical long-term success of the Ross procedure.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25076542

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  9 in total

1.  Pulmonary autograft in aortic position: is everything known?

Authors:  Francesco Nappi; Antonio Nenna; Cristiano Spadaccio; Massimo Chello
Journal:  Transl Pediatr       Date:  2017-01

Review 2.  The use of allogenic and autologous tissue to treat aortic valve endocarditis.

Authors:  Francesco Nappi; Sanjeet Singh Avtaar Singh; Mario Lusini; Antonio Nenna; Ivancarmine Gambardella; Massimo Chello
Journal:  Ann Transl Med       Date:  2019-09

Review 3.  Old Myths, New Concerns: the Long-Term Effects of Ascending Aorta Replacement with Dacron Grafts. Not All That Glitters Is Gold.

Authors:  Cristiano Spadaccio; Francesco Nappi; Nawwar Al-Attar; Fraser W Sutherland; Christophe Acar; Antonio Nenna; Marcella Trombetta; Massimo Chello; Alberto Rainer
Journal:  J Cardiovasc Transl Res       Date:  2016-05-31       Impact factor: 4.132

Review 4.  Biomechanical future of the growing pulmonary autograft in Ross operation.

Authors:  Francesco Nappi; Sanjeet Singh Avtaar Singh; Christophe Acar
Journal:  Transl Pediatr       Date:  2020-04

Review 5.  The effectiveness and safety of pulmonary autograft as living tissue in Ross procedure: a systematic review.

Authors:  Francesco Nappi; Adelaide Iervolino; Sanjeet Singh Avtaar Singh
Journal:  Transl Pediatr       Date:  2022-02

6.  Preconditioning process for dermal tissue decellularization using electroporation with sonication.

Authors:  Min-Ah Koo; HaKyeong Jeong; Seung Hee Hong; Gyeung Mi Seon; Mi Hee Lee; Jong-Chul Park
Journal:  Regen Biomater       Date:  2021-12-02

Review 7.  Biomechanics of Pulmonary Autograft as Living Tissue: A Systematic Review.

Authors:  Francesco Nappi; Sanjeet Singh Avtaar Singh
Journal:  Bioengineering (Basel)       Date:  2022-09-08

8.  The future of Ross procedure.

Authors:  Francesco Nappi; Cristiano Spadaccio; Christophe Acar
Journal:  Ann Pediatr Cardiol       Date:  2015 Sep-Dec

Review 9.  The Choice of Pulmonary Autograft in Aortic Valve Surgery: A State-of-the-Art Primer.

Authors:  Francesco Nappi; Sanjeet Singh Avtaar Singh; Francesca Bellomo; Pierluigi Nappi; Adelaide Iervolino; Christophe Acar
Journal:  Biomed Res Int       Date:  2021-04-13       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.